Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2162-3619
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis ; volume:1 ; number:1 ; day:23 ; month:4 ; year:2012 ; pages:1-9 ; date:12.2012
Experimental hematology & oncology ; 1, Heft 1 (23.4.2012), 1-9, 12.2012
- Creator
-
Rafiyath, Shamudheen M.
Rasul, Mohammad
Lee, Byung
Wei, Guoqing
Lamba, Gurpreet
Liu, Delong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/2162-3619-1-10
- URN
-
urn:nbn:de:101:1-2021081411014667187520
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rafiyath, Shamudheen M.
- Rasul, Mohammad
- Lee, Byung
- Wei, Guoqing
- Lamba, Gurpreet
- Liu, Delong
- SpringerLink (Online service)
Other Objects (12)
Doxorubicin-induced ovarian toxicity
Kinetic Targeting of pegylated liposomal Doxorubicin: a new Approach to Reduce Toxicity during Chemotherapy (CARL-trial)
Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts
Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
Tierexperimentelle Untersuchung an der Ratte : die Wirkung von Doxorubicin und liposomal verkapseltem Doxorubicin auf Immunsystem und Metastasenbildung
Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer
A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
Dexrazoxane prevents vascular toxicity in doxorubicin-treated mice
Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment
Doxorubicin-induced ovarian toxicity
Kinetic Targeting of pegylated liposomal Doxorubicin: a new Approach to Reduce Toxicity during Chemotherapy (CARL-trial)
Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts
Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
Tierexperimentelle Untersuchung an der Ratte : die Wirkung von Doxorubicin und liposomal verkapseltem Doxorubicin auf Immunsystem und Metastasenbildung
Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer
A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
Dexrazoxane prevents vascular toxicity in doxorubicin-treated mice
Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment
Doxorubicin-induced ovarian toxicity
Kinetic Targeting of pegylated liposomal Doxorubicin: a new Approach to Reduce Toxicity during Chemotherapy (CARL-trial)
Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts
Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
Tierexperimentelle Untersuchung an der Ratte : die Wirkung von Doxorubicin und liposomal verkapseltem Doxorubicin auf Immunsystem und Metastasenbildung
Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer
A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
Dexrazoxane prevents vascular toxicity in doxorubicin-treated mice